NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/11/2023
Back to search
Official data from USPTO
CLICK ACTIVATED PROTODRUGS AGAINST CANCER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLICK ACTIVATED PROTODRUGS AGAINST CANCER
ST13
US500000090291548Class
5
Filing
90291548
Registration
7027997
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
04/11/2023
Trademark type
Word
Nice classes
5
Filing date
10/31/2020
Registration date
04/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2023
Last transaction
04/11/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2022-08-00
First use in commerce
2022-08-00
Drawing code
4
Owner type
03
Owner location
San Francisco, CA
Examiner
GULIANO, ROBERT
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Shasqi, Inc.
Representatives
Evan A. Raynes SYMBUS LAW GROUP PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
40 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
04/11/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/08/2023
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
03/02/2023
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
03/01/2023
IUAA
USE AMENDMENT ACCEPTED
03/01/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
01/27/2023
IUAF
USE AMENDMENT FILED
01/27/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
01/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/26/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/26/2022
GNRT
NON-FINAL ACTION E-MAILED
07/26/2022
CNRT
NON-FINAL ACTION WRITTEN
07/26/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2022
NREV
NOTICE OF REVIVAL - E-MAILED
06/17/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/17/2022
PETG
PETITION TO REVIVE-GRANTED
06/17/2022
PROA
TEAS PETITION TO REVIVE RECEIVED
06/17/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/15/2021
GNRT
NON-FINAL ACTION E-MAILED
12/15/2021
CNRT
NON-FINAL ACTION WRITTEN
12/15/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
11/18/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/17/2021
ATRV
ATTORNEY REVIEW COMPLETED
11/10/2021
DRRR
DIVISIONAL REQUEST RECEIVED
10/18/2021
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
10/18/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
10/18/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/13/2021
ALIE
ASSIGNED TO LIE
10/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/05/2021
GNRT
NON-FINAL ACTION E-MAILED
04/05/2021
CNRT
NON-FINAL ACTION WRITTEN
04/05/2021
DOCK
ASSIGNED TO EXAMINER
04/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/27/2020
NWAP
NEW APPLICATION ENTERED
11/04/2020
Continuous trademark protection
Get notified about every new filing that threatens CLICK ACTIVATED PROTODRUGS AGAINST CANCER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.